广康生化(300804.SZ)特定股东拟减持减持合计不超4.4592%股份

Core Viewpoint - Guangkang Biochemical (300804.SZ) announced that specific shareholders plan to reduce their holdings in the company through centralized bidding and block trading within three months from the announcement date [1] Group 1: Shareholder Reduction Plans - Shareholders Huatuo Zhiying No. 2 Investment Partnership and Huatuo Zhiyuan No. 3 Investment Enterprise plan to collectively reduce their holdings by no more than 1.3198 million shares, which accounts for 1.7835% of the company's total share capital [1] - Shareholder Ruihong Kaiyin No. 1 Equity Investment Fund plans to reduce its holdings by no more than 1.98 million shares, representing 2.6757% of the company's total share capital [1]